These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28368454)

  • 1. Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats.
    Ball JP; Syed M; Marañon RO; Hall ME; Kc R; Reckelhoff JF; Yanes Cardozo LL; Romero DG
    Endocrinology; 2017 Jun; 158(6):1859-1874. PubMed ID: 28368454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunction.
    Syed M; Ball JP; Mathis KW; Hall ME; Ryan MJ; Rothenberg ME; Yanes Cardozo LL; Romero DG
    Am J Physiol Endocrinol Metab; 2018 Dec; 315(6):E1154-E1167. PubMed ID: 30153065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats.
    Peng H; Carretero OA; Raij L; Yang F; Kapke A; Rhaleb NE
    Hypertension; 2001 Feb; 37(2 Pt 2):794-800. PubMed ID: 11230375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
    Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
    Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
    López-Andrés N; Martin-Fernandez B; Rossignol P; Zannad F; Lahera V; Fortuno MA; Cachofeiro V; Díez J
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2372-82. PubMed ID: 21926338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
    Brilla CG; Matsubara LS; Weber KT
    J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury.
    Zhang Y; Peng W; Ao X; Dai H; Yuan L; Huang X; Zhou Q
    PLoS One; 2015; 10(11):e0142456. PubMed ID: 26556241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone-induced inflammation in the rat heart : role of oxidative stress.
    Sun Y; Zhang J; Lu L; Chen SS; Quinn MT; Weber KT
    Am J Pathol; 2002 Nov; 161(5):1773-81. PubMed ID: 12414524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of microRNAs and renin-angiotensin system in high salt diet-induced cardiac dysfunction in uninephrectomized rats.
    Amara VR; Surapaneni SK; Tikoo K
    PLoS One; 2017; 12(7):e0180490. PubMed ID: 28727756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.
    Rocha R; Martin-Berger CL; Yang P; Scherrer R; Delyani J; McMahon E
    Endocrinology; 2002 Dec; 143(12):4828-36. PubMed ID: 12446610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of felodipine on myocardial and renal injury induced by aldosterone-high salt hypertension in uninephrectomized rats.
    Matsubara BB; Franco M; Janicki JS; Matsubara LS
    Braz J Med Biol Res; 2010 May; 43(5):506-14. PubMed ID: 20490436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-181a is a novel regulator of aldosterone-mineralocorticoid receptor-mediated cardiac remodelling.
    Garg A; Foinquinos A; Jung M; Janssen-Peters H; Biss S; Bauersachs J; Gupta SK; Thum T
    Eur J Heart Fail; 2020 Aug; 22(8):1366-1377. PubMed ID: 32304626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between cardiac and arterial fibrosis and stiffness in aldosterone-salt rats: effect of eplerenone.
    Nehme J; Mercier N; Labat C; Benetos A; Safar ME; Delcayre C; Lacolley P
    J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):31-9. PubMed ID: 17083071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade.
    Ramires FJ; Sun Y; Weber KT
    J Mol Cell Cardiol; 1998 Mar; 30(3):475-83. PubMed ID: 9515025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretics and bone loss in rats with aldosteronism.
    Law PH; Sun Y; Bhattacharya SK; Chhokar VS; Weber KT
    J Am Coll Cardiol; 2005 Jul; 46(1):142-6. PubMed ID: 15992648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoids, hypertension, and cardiac fibrosis.
    Young M; Fullerton M; Dilley R; Funder J
    J Clin Invest; 1994 Jun; 93(6):2578-83. PubMed ID: 8200995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SB-216763, a GSK-3β inhibitor, protects against aldosterone-induced cardiac, and renal injury by activating autophagy.
    Zhang YD; Ding XJ; Dai HY; Peng WS; Guo NF; Zhang Y; Zhou QL; Chen XL
    J Cell Biochem; 2018 Jul; 119(7):5934-5943. PubMed ID: 29600538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress.
    Yoshida K; Kim-Mitsuyama S; Wake R; Izumiya Y; Izumi Y; Yukimura T; Ueda M; Yoshiyama M; Iwao H
    Hypertens Res; 2005 May; 28(5):447-55. PubMed ID: 16156509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
    Brilla CG; Weber KT
    J Lab Clin Med; 1992 Dec; 120(6):893-901. PubMed ID: 1453111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.